PL3300730T3 - Zastosowanie medyczne 5,7-dihydroksy-3-(4-hydroksyfenylo)-4H-1-benzopiran-4-onu w terapii choroby Huntingtona oraz farmaceutycznie akceptowalna postać leku - Google Patents
Zastosowanie medyczne 5,7-dihydroksy-3-(4-hydroksyfenylo)-4H-1-benzopiran-4-onu w terapii choroby Huntingtona oraz farmaceutycznie akceptowalna postać lekuInfo
- Publication number
- PL3300730T3 PL3300730T3 PL17001178.7T PL17001178T PL3300730T3 PL 3300730 T3 PL3300730 T3 PL 3300730T3 PL 17001178 T PL17001178 T PL 17001178T PL 3300730 T3 PL3300730 T3 PL 3300730T3
- Authority
- PL
- Poland
- Prior art keywords
- benzopiran
- dihydroxy
- hydroxyphenyl
- therapy
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL417983A PL417983A1 (pl) | 2016-07-15 | 2016-07-15 | Zastosowanie medyczne 5,7-dihydroksy-3-(4-hydroksyfenylo)-4H-1-benzopiran-4-onu w terapii choroby Huntingtona oraz farmaceutycznie akceptowalna postać leku |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3300730T3 true PL3300730T3 (pl) | 2024-08-26 |
Family
ID=61006882
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL417983A PL417983A1 (pl) | 2016-07-15 | 2016-07-15 | Zastosowanie medyczne 5,7-dihydroksy-3-(4-hydroksyfenylo)-4H-1-benzopiran-4-onu w terapii choroby Huntingtona oraz farmaceutycznie akceptowalna postać leku |
| PL17001178.7T PL3300730T3 (pl) | 2016-07-15 | 2017-07-11 | Zastosowanie medyczne 5,7-dihydroksy-3-(4-hydroksyfenylo)-4H-1-benzopiran-4-onu w terapii choroby Huntingtona oraz farmaceutycznie akceptowalna postać leku |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL417983A PL417983A1 (pl) | 2016-07-15 | 2016-07-15 | Zastosowanie medyczne 5,7-dihydroksy-3-(4-hydroksyfenylo)-4H-1-benzopiran-4-onu w terapii choroby Huntingtona oraz farmaceutycznie akceptowalna postać leku |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP3300730B1 (pl) |
| PL (2) | PL417983A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL440896A1 (pl) | 2022-04-11 | 2023-10-16 | Uniwersytet Gdański | Genisteina do zastosowania w zapobieganiu utraty pamięci i zdolności poznawczych ludzi zdrowych w wyniku stopniowych występujących fizjologicznie u osób zdrowych procesów starzenia się mózgu z wiekiem jako czynnik zapobiegający i zmniejszający odkładanie się szkodliwych nierozpuszczalnych agregatów i złogów białek w mózgu, zwłaszcza beta-amyloidu |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070203079A1 (en) * | 2005-11-21 | 2007-08-30 | Caldwell Guy A | Methods of using small molecule compounds for neuroprotection |
-
2016
- 2016-07-15 PL PL417983A patent/PL417983A1/pl unknown
-
2017
- 2017-07-11 PL PL17001178.7T patent/PL3300730T3/pl unknown
- 2017-07-11 EP EP17001178.7A patent/EP3300730B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL417983A1 (pl) | 2018-01-29 |
| EP3300730B1 (en) | 2024-04-03 |
| EP3300730A1 (en) | 2018-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024010140A (es) | Nuevos metodos. | |
| WO2015165413A8 (zh) | 一种新型的稳定型抗体药物耦联物及其制备方法和用途 | |
| HUE055873T2 (hu) | Arany klaszter (AuCs) vagy AuCs-t tartalmazó anyagok alkalmazása glaukóma megelõzésére és/vagy kezelésére szolgáló gyógyszer elõállítására | |
| WO2015160975A3 (en) | Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer | |
| MX383665B (es) | Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer. | |
| IL260955A (en) | A mini tablet for oral administration containing sacubitril and valsartan for the treatment of heart failure | |
| HK1223304A1 (zh) | 包含二甲双胍和二氢槲皮素的药物组合及其用於治疗癌症的用途 | |
| EP3015111A4 (en) | Use of chinese medicine preparation in preparing drug for preventing and/or treating crohn's disease | |
| WO2015173701A3 (en) | Pharmaceutical compositions comprising danirixin for treating infectious diseases | |
| CY1119532T1 (el) | (s)-πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη | |
| IL264407A (en) | Novel application of gzd824 and pharmaceutically acceptable salts thereof in treating diseases | |
| PT3215143T (pt) | Combinação compreendendo espirulina e palmitoíletanolamida | |
| IL259710A (en) | Compositions and methods of treatment for mvid and related diseases | |
| HK1225972A1 (zh) | 利用拉喹莫德来延缓亨廷顿氏病的进展 | |
| EP3639839A4 (en) | PEPTIDE WITH ANTIDEPRESSIVE EFFECT AND THERAPEUTIC EFFECT AGAINST ALZHEIMER'S MORBUS | |
| CY1119522T1 (el) | (r)- πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη | |
| MX2018002298A (es) | Metodos de uso de interleucina 10 para el tratamiento de enfermedades y trastornos. | |
| IL282142A (en) | The history of 4-pyrazine-2-ylmethyl-morpholine and its use as a medicine | |
| PL3300730T3 (pl) | Zastosowanie medyczne 5,7-dihydroksy-3-(4-hydroksyfenylo)-4H-1-benzopiran-4-onu w terapii choroby Huntingtona oraz farmaceutycznie akceptowalna postać leku | |
| EP3844168A4 (en) | COMBINATION DRUG PREPARATIONS FOR THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASE AND ASSOCIATED CONDITIONS | |
| EP3162377A4 (en) | Use of -asarone in preparing drugs for preventing and treating alzheimer's disease | |
| TWI799923B (zh) | 硫代咪唑烷酮藥物在治療covid-19疾病中的用途 | |
| PL3085383T3 (pl) | Kompozycja farmaceutyczna zawierająca erytropoietynę i ceftriakson oraz jej wykorzystanie w wytwarzania leku do leczenia choroby parkinsona | |
| GB201914886D0 (en) | Medicine/Ailments and diseases | |
| EA201692163A1 (ru) | Лекарственное средство для лечения пациентов с тиннитусом |